Skip to main content
. 2020 May 13;34:101574. doi: 10.1016/j.redox.2020.101574

Fig. 2.

Fig. 2

sgp130Fc treatment reduces oxidative stress in diabetic mice at systemic level and in the vitreous fluid. (A) Serum IL-6 levels, (B) total antioxidant capacity in serum, (C) MDA levels in plasma, and (D) carbonyl content in vitreous fluid were measured in control and diabetic mice with and without sgp130Fc treatment. Results are expressed as mean ± SEM. *p < 0.05 vs control. †p < 0.05 vs STZ.